8(R)-methyloleandomycin

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 8(R)-methyloleandomycin
• 英文别名: (3R,4S,5R,6S,7S,9S,11R,12S,13R,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-12-hydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-3,5,7,9,11,13,14-heptamethyl-oxacyclotetradecane-2,10-dione
• 化学式: C₃₅H₆₃NO₁₁
• 分子量: 673.885
• InChiKey: HMWRDHJSNPHWRP-FOWLLSGPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  47
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.94
• 拓扑面积：
  153
• 氢给体数：
  3
• 氢受体数：
  12

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  ——	8-methylene-oleandomycin	64774-87-4	C35H61NO11	671.869
  竹桃霉素	oleandomycin	3922-90-5	C35H61NO12	687.869

反应信息

• 作为反应物：
  描述：

  8(R)-methyloleandomycin 在 吡啶 、 盐酸羟胺 作用下， 反应 30.0h， 以57%的产率得到8(R)-methyloleandomycin-9-oxime
  参考文献：
  名称：

  New oleandomycin 9-oximes. Synthesis, characterization and biological activity.

  摘要：

  一系列新型奥利安霉素9-肟已被制备并通过光谱数据和X射线分析进行了表征。这些肟（6-10）的体外抗菌活性与奥利安霉素（1）进行了比较。在新衍生物中，活性最强的化合物是8(R)-三乙基奥利安霉素-9-肟（9），而其8(S)-异构体（10）则仅具有低活性。一些初步的药代动力学数据显示了9的活性。化合物9已被推进至进一步的生物研究。

  DOI：

  10.7164/antibiotics.47.349
• 作为产物：
  描述：

  竹桃霉素 在 chromium dichloride 、 sodium dithionite 、 碳酸氢钠 作用下， 以 1,4-二氧六环 、 水 、 丙酮 为溶剂， 130.0 ℃ 、200.0 kPa 条件下， 反应 0.02h， 生成 8(S)-methyloleandomycin 、 8(R)-methyloleandomycin
  参考文献：
  名称：

  Impact of stereochemistry on the biological activity of novel oleandomycin derivatives

  摘要：

  A set of 8-methylene-, 8-methyl-, and 8-methyl-9-dihydro-oleandomycin derivatives having different combinations of stereochemistries at positions C-8 and/or C-9 have been prepared in a chemoselective and stereoselective manner and tested in vitro for antibacterial activity and inhibition of IL-6 production. Configurations of the stereocenters at C-8 and C-9 were determined using 2D NMR techniques. We have shown that change of stereochemistry at these positions can exert a major influence on antibacterial activity as well as IL-6 inhibition, providing novel macrolide derivatives with diminished antibacterial and potent anti-inflammatory activity. In addition, the anti-inflammatory activity observed in vitro was confirmed in an in vivo model of lipopolysaccharide-induced inflammation. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.02.013

文献信息

• Impact of stereochemistry on the biological activity of novel oleandomycin derivatives
  作者：Jurica Bauer、Mark Vine、Ilija Čorić、Martina Bosnar、Ivanka Pašalić、Gordana Turkalj、Gorjana Lazarevski、Ognjen Čulić、Goran Kragol

  DOI：10.1016/j.bmc.2012.02.013

  日期：2012.4

  A set of 8-methylene-, 8-methyl-, and 8-methyl-9-dihydro-oleandomycin derivatives having different combinations of stereochemistries at positions C-8 and/or C-9 have been prepared in a chemoselective and stereoselective manner and tested in vitro for antibacterial activity and inhibition of IL-6 production. Configurations of the stereocenters at C-8 and C-9 were determined using 2D NMR techniques. We have shown that change of stereochemistry at these positions can exert a major influence on antibacterial activity as well as IL-6 inhibition, providing novel macrolide derivatives with diminished antibacterial and potent anti-inflammatory activity. In addition, the anti-inflammatory activity observed in vitro was confirmed in an in vivo model of lipopolysaccharide-induced inflammation. (C) 2012 Elsevier Ltd. All rights reserved.
• New oleandomycin 9-oximes. Synthesis, characterization and biological activity.
  作者：GORJANA LAZAREVSKI、GABRIJELA KOBREHEL、SLOBODAN DOKIC、LIDIJA KOLACNY-BABIC、BISERKA KOJIC-PRODIC、DRAGAN JANKOVIC、VITOMIR PUNTAREC

  DOI：10.7164/antibiotics.47.349

  日期：——

  A series of the novel oleandomycin 9-oximes has been prepared and characterized by spectroscopic data and X-ray analysis. The antibacterial in vitro activities of the oximes (6-10) were compared with that of oleandomycin (1). Among the novel derivatives the most active compound was 8(R)-rriethyloleandomycin-9-oxime (9) in contrast to its 8(S)-isomer (10) which possessed only low potency. Some preliminary pharmacokinetic data of 9 confirmed its activity. Compound 9 has been advanced to further biological study.

  一系列新型奥利安霉素9-肟已被制备并通过光谱数据和X射线分析进行了表征。这些肟（6-10）的体外抗菌活性与奥利安霉素（1）进行了比较。在新衍生物中，活性最强的化合物是8(R)-三乙基奥利安霉素-9-肟（9），而其8(S)-异构体（10）则仅具有低活性。一些初步的药代动力学数据显示了9的活性。化合物9已被推进至进一步的生物研究。